Altria Group (NYSE:MO)
Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world’s largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company’s Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%). They are considered a leader in the cannabis and tobacco industry.
Get Real Time Here
| Open52.920 | Close53.840 |
| Vol / Avg.27.064M / 7.768M | Mkt Cap91.689B |
| Day Range52.850 - 53.880 | 52 Wk Range39.250 - 58.035 |
Jazz Pharmaceuticals (NASDAQ:JAZZ)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and indications in neuroscience and hematology-oncology. Jazz’s product portfolio includes its lead drug, Xyrem, for narcolepsy, Sunosi for improving wakefulness in patients with excessive daytime sleepiness, Defitelio for severe veno-occlusive disease after stem cell transplant, Vyxeos for acute myeloid leukemia, and Zepzelca for small cell lung cancer.
Get Real Time Here
| Open122.850 | Close122.970 |
| Vol / Avg.1.767M / 630.634K | Mkt Cap7.434B |
| Day Range121.370 - 124.390 | 52 Wk Range99.060 - 134.170 |
Village Farms Intl (NASDAQ:VFF)
As one of the largest and longest-operating greenhouse growers in North America, Village Farms International produces and distributes premium cannabis to national growers in the U.S. and Canada.
The cannabis stock has a market cap of $288 million and trades over 1 million shares per day. It has an EPS of $0.04 and a P/E ratio of 128. Village Farms International generated total revenue of $144 million in 2019, making it one of the best stocks under $10.
Village Farm International recently reported its revenue in Q1 2020 and declared that it has had a profitable business for the 5th consecutive quarter. The cannabis company has also announced that it has expanded its credit facility with its existing lender by $59 million.
Get Real Time Here
| Open0.740 | Close0.772 |
| Vol / Avg.474.400K / 461.265K | Mkt Cap88.724M |
| Day Range0.730 - 0.807 | 52 Wk Range0.580 - 1.620 |
GrowGeneration (NASDAQ:GRWG)
GrowGeneration Corp. is a premier supplier of cannabis and cannabis-growing equipment. These products include organic nutrients, drip systems, water pumps, air pumps, LED lights and commercial light systems. It is the largest hydroponic supplier in the U.S., with 31 retail and distribution centers.
The cannabis stock has a market cap of $849 million and has an EPS of $0.02. It has an annual dividend yield of $0.02 per share. GrowGeneration has high liquidity and trades more than 1.7 million shares per day. It generated revenue of $79 million in 2019.
Get Real Time Here
| Open1.600 | Close1.660 |
| Vol / Avg.1.152M / 568.020K | Mkt Cap97.753M |
| Day Range1.590 - 1.690 | 52 Wk Range1.552 - 3.380 |
AbbVie (NYSE:ABBV)
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The company’s top drug, Humira, represents close to half of the company’s current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women’s health.
Get Real Time Here
| Open171.794 | Close175.580 |
| Vol / Avg.18.951M / 6.087M | Mkt Cap309.027B |
| Day Range170.660 - 176.800 | 52 Wk Range151.290 - 207.320 |
After the legalization of marijuana in the U.S., many companies are actively engaged in the research, development and distribution of cannabis. Cannabidiol (CBD) is the non-psychoactive substance present within cannabis and its products such as CBD oil has had a major impact on the health and wellness industry. Take a look at these CBD oil stock picks that are generating millions of dollars in revenue this year.
Quick Look at the Best CBD Oil Stocks:
- Altria
- Jazz Pharmaceuticals
- Village Farm Inernational
- GrowGEneration Corp
- AbbVie
Overview: CBD Oil Stocks
Since ancient times, cannabis has been used as a form of medicine and as a means to induce euphoria. Indian sages have also mentioned the medicinal use of marijuana in Vedic hymns of antiquity.
However, President Richard Nixon banned the cultivation and sale of marijuana in the U.S. as part of his “war on drugs” campaign in 1970. It wasn’t until the Compassionate Use Act of 1996 was passed that California became the first state to legalize marijuana to treat people with severe or chronic diseases. As of 2022, 37 states in the U.S. have legalized the medical use of marijuana and 18 states have legalized the recreational use of marijuana.
According to a recent report by the New Frontier Data, the legal sale of cannabis could reach $30 billion by 2025. Due to such high potential to earn profits, alcohol companies have started to invest big in CBD oil companies.
Constellation Brands Inc. (NYSE: STZ) has invested billions in Canopy Growth Corp. (NYSE: CGC). Molson Coors (NYSE: TAP) invested billions in Hexo (TSX: HEXO). Budweiser (NYSE: BUD) entered a joint venture to develop non-alcoholic CBD drinks with Tilray Inc. (NASDAQ: TLRY).
You can still catch up with the market trend and gain some good earnings by investing in CBD oil stocks today.
Best Online Brokers for CBD Oil Stock
Online brokers let you browse and trade thousands of stocks listed on major stock exchanges. These platforms are bundled with tons of educational resources and tools to let you manage your stock portfolio on the go. Many of these online brokers also allow you to trade stocks commission-free.
Benzinga has handpicked these online brokers to get you started.
- Best For:Active and Global TradersVIEW PROS & CONS:Securely through Interactive Brokers’ website
- Best For:Global Broker for Short SellingVIEW PROS & CONS:securely through TradeZero's website
Features to Look for in CBD Oil Stock
- Profitable earnings per share: The earnings per share (EPS) of a company can tell you how much money you stand to make on each invested share. You can calculate the EPS of a company by dividing its net income by its total number of outstanding shares.
- Low price-earnings ratio: You can determine if a stock is undervalued or overpriced by its price-earnings (P/E) ratio. A high P/E ratio could indicate that the company stock is overpriced or that it may be expecting to grow in the coming months.
- Growth in yearly revenue: CBD oil companies have invested huge capital in top-notch equipment and warehouse facilities for producing and distributing high-quality marijuana plants. Be sure to go through their net income over the last few years to check if the company stock is growing or if it is underperforming in the market.
Don’t Panic, It’s Organic
Cannabis has worked wonders for many verticals such as sports, medicine and recreational art industries. CBD oil companies are constantly developing new strains of marijuana that are safe and accessible to their customers over the counter. Invest in CBD oil companies now and watch your wealth grow organically.
Frequently Asked Questions
Do people like CBD?
Being a newer product than marijuana itself, the growth of the CBD industry has shown us that people like the product and suggests growth in the industry will only continue.
What are CBD stocks?
CBD stocks are shares in companies in the CBD industry.
What are the best CBD oil stocks?
Benzinga offers a list above of the best CBD oil stocks.